Skip to main content
Premium Trial:

Request an Annual Quote

Agilent Board Approves $1.14B Share Buyback Program

NEW YORK (GenomeWeb) – Agilent Technologies today announced that its board has approved a share repurchase program for up to a $1.14 billion. 

The buyback program will run through Nov. 1, 2018 and will begin either on Nov. 1, 2015 or when Agilent's previous buyback program is completed. The existing program has $365 million remaining, the Santa Clara, California-based firm said. 

Earlier this month, Agilent reported a 3 percent drop in its fiscal second quarter revenues.

The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.